Tidal Energy Generation Systems Market to grow by USD 0.47 million from 2024-2028, driven by rising demand for renewable electricity and AI-powered market evolution- Technavio
NEW YORK, Oct. 25, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Global Tidal Energy Generation Systems Market size is estimated to grow by USD 0.47 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 16.61% during the forecast period. Growing demand for electricity from renewable energy sources is driving market growth, with a trend towards integration of AI and ML into tidal energy generation systems. However, high cost of manufacture and maintenance for tidal energy generation systems poses a challenge.Key market players include ABB Ltd., Andritz AG, BioPower Systems Pty Ltd., Blue Energy Canada Inc., Bluewater Energy Services BV, DP Energy, HydroWing, Instream Energy Systems Corp., Nova Innovation Ltd., Ocean Renewable Power Co. Inc., Orbital Marine Power Ltd, Proteus Marine Renewables, QED Naval Limited, SABELLA SA, Simec Atlantis Energy Ltd., Seabased, SeaQurrent, and Verdant Power Inc..
Technavio has announced its latest market research report titled Global tidal energy generation systems market 2024-2028
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now
Forecast period
2024-2028
Base Year
2023
Historic Data
2018 - 2022
Segment Covered
Type (Tidal range devices, Dynamic tidal power, Tidal stream systems, and Others), Application (Utility-scale projects, Microgrid systems, and Off-grid systems), and Geography (Europe, APAC, North America, Middle East and Africa, and South America)
Region Covered
Europe, APAC, North America, Middle East and Africa, and South America
Key companies profiled
ABB Ltd., Andritz AG, BioPower Systems Pty Ltd., Blue Energy Canada Inc., Bluewater Energy Services BV, DP Energy, HydroWing, Instream Energy Systems Corp., Nova Innovation Ltd., Ocean Renewable Power Co. Inc., Orbital Marine Power Ltd, Proteus Marine Renewables, QED Naval Limited, SABELLA SA, Simec Atlantis Energy Ltd., Seabased, SeaQurrent, and Verdant Power Inc.
Key Market Trends Fueling Growth
The integration of artificial intelligence (AI) and machine learning (ML) into tidal energy generation systems is revolutionizing the global tidal energy market. AI and ML technologies are used to enhance the efficiency, reliability, and performance of tidal energy devices. In operation and maintenance, AI algorithms analyze operational data to identify patterns, predict equipment failures, and enable proactive maintenance, reducing downtime and improving reliability. ML techniques develop predictive maintenance models for timely interventions and cost savings. AI-driven control systems optimize power output and equipment longevity by processing real-time data on tidal patterns, current speeds, and device behavior. AI and ML are also used for resource assessment and site selection, identifying optimal locations and predicting power generation potential. Additionally, AI-powered optimization algorithms enhance grid integration by forecasting tidal energy production, managing grid stability, and optimizing energy trading. These advancements are expected to boost tidal energy adoption and market growth.
Story Continues
Tidal energy generation systems are gaining popularity as a renewable power source, harnessing the kinetic energy from tidal currents and tidal lagoons. Two main types exist: tidal barrages using vertical and axial turbines, and tidal stream systems with horizontal axis and vertical axis turbines, plus tidal kites. Orbital Marine Power leads the way with dynamic tidal power. Tidal energy is a valuable addition to renewable energy sources like solar and wind, addressing electricity demand during peak hours and providing base load power. It also offers potential for desalination and reducing greenhouse gas emissions, contributing to energy security and sustainable energy. Ocean energy technologies, including wave energy converters, are complementary, expanding the renewable energy mix and reducing reliance on fossil fuels. Climate change mitigation and carbon emissions reduction are key benefits.
Insights on how AI is driving innovation, efficiency, and market growth- Request Sample!
Market Challenges
The tidal energy generation market faces significant challenges due to the high cost of manufacturing and maintaining tidal energy systems. Tidal energy, as a renewable and sustainable power source, utilizes the kinetic energy of ocean tides to generate electricity. However, the complex design and engineering needed to build systems capable of withstanding harsh marine conditions and efficiently converting tidal forces into electricity drive up manufacturing expenses. The development of infrastructure, including tidal turbines, support structures, electrical components, and grid connections, necessitates specialized materials, technology, and expertise, all contributing to increased manufacturing costs. The need for durable, corrosion-resistant materials, reliable equipment, and advanced control systems further amplifies costs, making it difficult for new players to enter the tidal energy sector. Moreover, the challenging operating conditions in marine environments necessitate regular monitoring, servicing, and repair activities to ensure optimal performance and longevity. Maintenance in offshore and subsea settings requires specialized vessels, equipment, and skilled personnel, adding to the overall operating costs of tidal energy projects. The remote location and logistical complexities of many tidal energy sites escalate maintenance expenses and operational downtime, negatively impacting the cost-effectiveness and reliability of tidal energy generation systems. These factors hinder the widespread adoption and scalability of tidal energy generation systems in the market, posing a significant challenge to the growth of the global tidal energy generation systems market during the forecast period.
Tidal energy generation systems tap into the kinetic energy of tidal currents and tidal lagoons, converting it into electricity. Technologies include tidal barrages, horizontal axis turbines, and vertical axis turbines. Challenges include the high capital costs of tidal barrages and the complexity of horizontal and vertical axis turbines. Emerging solutions like tidal kites and dynamic tidal power show promise. Companies like Orbital Marine Power lead the way in tidal power innovation. Renewable energy sources, including tidal energy, are crucial for meeting growing electricity demand and reducing reliance on fossil fuels. Tidal energy can also contribute to desalination and climate change mitigation by providing sustainable energy and reducing greenhouse gas emissions. Ocean energy technologies, including wave energy converters and tidal energy, offer diverse solutions for a carbon-neutral future.
Insights into how AI is reshaping industries and driving growth- Download a Sample Report
Segment Overview
This tidal energy generation systems market report extensively covers market segmentation by
Type 1.1 Tidal range devices
1.2 Dynamic tidal power
1.3 Tidal stream systems
1.4 Others
Application 2.1 Utility-scale projects
2.2 Microgrid systems
2.3 Off-grid systems
Geography 3.1 Europe
3.2 APAC
3.3 North America
3.4 Middle East and Africa
3.5 South America
1.1 Tidal range devices- Tidal energy generation systems convert the power of ocean waves into electricity. These systems consist of turbines placed underwater that rotate when hit by tidal currents. Companies like Siemens Gamesa and Andritz Hydro are key players in this market, supplying turbines and turnkey solutions. The global tidal energy market is expected to grow significantly due to increasing demand for renewable energy sources and technological advancements. Government incentives and partnerships also boost the industry's growth.
Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022)
Research Analysis
Tidal energy and wave energy are forms of ocean energy that harness the power of the tides and ocean waves to generate electricity. Renewable energy sources, including tidal energy, are becoming increasingly important in the global energy landscape as the world transitions away from fossil fuels to reduce greenhouse gas emissions and mitigate climate change. Tidal energy generation systems utilize various technologies such as tidal barrages, horizontal axis turbines, vertical axis turbines, tidal kites, and dynamic tidal power to convert the kinetic energy of tidal currents into electricity. Tidal power can also be used for desalination, providing sustainable water sources in arid regions. The market for tidal energy generation systems is expected to grow significantly due to the increasing demand for sustainable energy, energy security, and the need to reduce carbon emissions. Technologies like axial turbines, crossflow turbines, and tidal lagoons are also gaining popularity in the tidal energy sector. Companies are investing heavily in research and development to improve the efficiency and cost-effectiveness of tidal energy generation systems. Ocean energy, including tidal and wave energy, is a promising source of renewable energy that can contribute significantly to a sustainable and low-carbon future.
Market Research Overview
Tidal energy, a form of ocean energy, is a promising renewable power generation system that converts the kinetic energy of tidal currents into electricity. This sustainable energy source is gaining popularity as a viable alternative to fossil fuels in the context of climate change and increasing greenhouse gas emissions. Wave energy, another ocean energy source, is also making strides in the power generation sector. Together, wave and tidal energy are part of the larger category of ocean energy technologies, which include tidal barrages, wave energy converters, and various types of turbines such as horizontal axis, vertical axis, axial, and crossflow. These systems have the potential to provide electricity for desalination and contribute to energy security, reducing carbon emissions and meeting growing electricity demand. Tidal currents, a constant and predictable energy source, offer dynamic tidal power that can be harnessed through various methods, including tidal lagoons and tidal kites. Orbital Marine Power, a leading company in tidal stream technology, is developing innovative solutions to maximize the potential of tidal energy. The renewable energy sources of tidal and wave energy are set to play a significant role in the future of power generation.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation Type
Application
Geography
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/ Global tidal energy generation systems market 2024-2028 Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/tidal-energy-generation-systems-market-to-grow-by-usd-0-47-million-from-2024-2028--driven-by-rising-demand-for-renewable-electricity-and-ai-powered-market-evolution--technavio-302286486.html
SOURCE Technavio
Hashtags
- Business#USD,Technavio,ABBLtd.,AndritzAG,BioPowerSystemsPtyLtd.,BlueEnergyCanadaInc.,BluewaterEnergyServicesBV,DPEnergy,HydroWing,InstreamEnergySystemsCorp.,NovaInnovationLtd.,OceanRenewablePowerCo.Inc.,OrbitalMarinePowerLtd,ProteusMarineRenewables,QEDNavalLimited,SABELLASA,SimecAtlantisEnergyLtd.,Seabased,SeaQurrent,PRNewswire,VerdantPowerInc.,VerdantPowerInc
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer
Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting Data show low rates of treatment-related adverse events, signaling human kallikrein 2 (KLK2) as a novel, highly specific target CHICAGO, June 1, 2025 /PRNewswire/ -- Johnson & Johnson announced today new data from a Phase 1 study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific antibody that activates T-cells to harness the body's immune system against prostate cancer cells, showing promise in patients with advanced disease who have progressed after multiple lines of therapy. These first data on pasritamig, from the first-in-human study, demonstrate that pasritamig appears well-tolerated and exhibits a promising antitumor activity in patients with metastatic castration-resistant prostate cancer (mCRPC), highlighting the potential of KLK2 as a novel target for T-cell engagement in advanced disease.1 These data were presented as an oral presentation (Abstract #5017) at the 2025 American Society of Clinical Oncology Annual Meeting and published simultaneously in The Journal of Clinical Oncology. Pasritamig is a novel T-cell engager designed to bind both CD3 on T-cells and KLK2—a prostate-specific antigen with minimal expression outside of the prostate. Pasritamig activates T-cells by binding to CD3 and directing them to KLK2- expressing tumor cells, engaging the body's immune system to specifically target these cancerous cells. This differentiated approach aims to deliver a targeted treatment for patients with advanced prostate cancer, while potentially reducing the high-grade toxicities historically associated with T-cell engagers. "These first-in-human results for pasritamig are highly encouraging, demonstrating that KLK2 is a viable target for T-cell engagers in metastatic castration-resistant prostate cancer," said Capucine Baldini*, M.D., Ph.D., Drug Development Department (DITEP), Institut Gustave Roussy, and presenting author. "The data show a promising safety profile, with manageable adverse events and no AEs leading to treatment discontinuations or ICANS observed, with 40 percent of patients having no treatment-related AEs at all. Given the limited treatment options for mCRPC, these findings support further investigation of pasritamig and the role of KLK2-targeted T-cell therapies as a potential new approach for patients with aggressive disease." "Metastatic castration-resistant prostate cancer remains one of the most difficult stages of prostate cancer to treat, particularly for patients who haven't responded well to previous treatments," said Jeff Infante, M.D., Vice President of Early Clinical Development and Translational Research at Johnson & Johnson Innovative Medicine. "This investigational approach underscores our commitment to developing innovative and practice-changing medicines that are well-tolerated and can be easily administered in community practice settings." The Phase 1 first-in-human study (NCT04898634) evaluated 174 patients with ages ranging from 36 to 89 years old and on average having received four prior therapies (range 1-13). The recommended phase 2 dose (RP2D) of pasritamig was 3.5mg on day 1, 18mg on day 8, 300mg intravenously on day 15 and then once every six weeks. The RP2D safety group also included patients treated once every three weeks as the toxicity profiles were very similar. The RP2D efficacy group only included patients treated at the RP2D once every six weeks.1 Within the RP2D safety group (n=45), treated once every three or six weeks, 100 percent had previously received androgen receptor pathway inhibitors, 75.6 percent had undergone taxane chemotherapy, and 37.8 percent had been treated with Lutetium 177 vipivotide tetraxetan prostate-specific membrane antigen radioligand therapy.1 The most common treatment- related adverse events (TRAEs) were Grade 1/2 infusion-related reactions (24.4 percent), Grade 1 cytokine release syndrome (CRS) presenting as fever only (8.9 percent, no steroid or tocilizumab was administered) and no reports of higher grade CRS. No TRAEs leading to treatment discontinuation or dose reduction were reported and no immune effector cell-associated neurotoxicity syndrome (ICANS) was observed. Grade 3 TRAEs were infrequent with 4.4 percent of patients reporting transient AST/ALT increases and neutropenia. There were no dose-limiting toxicities reported. The favorable safety profile of the RP2D regimen enabled convenient outpatient administration on a patient-friendly, once-every-six-weeks schedule.1 Of the patients in the RP2D efficacy group (n=33), treated once every six weeks, 42.4 percent achieved a 50 percent or greater reduction in their prostate-specific antigen (PSA) levels with a median rPFS of 7.9 months (95 percent confidence interval [CI] 2.9, not estimable [NE]) and 21.2 percent of patients continuing therapy. Treatment with pasritamig showed durable disease control and rPFS that compares favorably to historical data in heavily pretreated patients with mCRPC.1 Metastatic castration-resistant prostate cancer occurs in a significant portion of prostate cancer patients, with many progressing despite initial therapies.2 Overall survival from diagnosis of mCRPC patients ranges from 13.5 to 31.6 months, and lower in patients who have progressed on therapy.3 Treatment options remain limited, underscoring the urgent need for safer and more effective therapies.4 About Pasritamig (JNJ-78278343)Pasritamig (JNJ-78278343) is an investigational T-cell-engaging bispecific antibody (bsAb) targeting human kallikrein 2 (KLK2) on prostate cancer cells and CD3 on T-cells. This approach is being evaluated in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC), a patient population with limited treatment options. About Metastatic Castration-Resistant Prostate Cancer (mCRPC)Metastatic castration-resistant prostate cancer (mCRPC) is a challenging and aggressive stage of prostate cancer where the disease progresses despite androgen deprivation therapy.2 Patients often experience metastasis to bones and lymph nodes, leading to poor outcomes and limited treatment options, including chemotherapy and second-line hormone therapies.5 The median overall survival ranges from 13.5 to 31.6 months depending on the site of metastasis, with a typical range of 15–36 months across the broader population.3,6 Survival rates can vary significantly depending on factors such as prior treatment history, disease burden, and response to therapy. The need for more effective treatments is critical, as the disease continues to impact a large number of men globally, with mCRPC being responsible for a substantial number of prostate cancer-related deaths. About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at or at Follow us at @JNJInnovMed. Janssen Research & Development, LLC, Janssen Biotech, Inc., Janssen Global Services, LLC and Janssen Scientific Affairs, LLC are Johnson & Johnson companies. Cautions Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding product development and the potential benefits and treatment impact of JNJ-78278343. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behavior and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments. Source: Johnson & Johnson *Dr. Capucine Baldini has provided consulting, advisory, and speaking services to Johnson & Johnson; Dr. Baldini has not been paid for any media work. 1 Baldini, C., et al. Phase 1 Study Results of Pasritamig (JNJ-78278343) in Metastatic Castration-Resistant Prostate Cancer. 2025 American Society of Clinical Oncology Annual Meeting. June 2025.2 Scher, H. I., et al. (2016). "Treatment of castration-resistant prostate cancer: Current and future strategies." Nature Reviews Clinical Oncology, 13(10), 577-590.3 Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States. Cancer Causes Control. 2021;32(12):1365-1374. doi:10.1007/s10552-021-01484-44 Ravi P, Mateo J, Lorente D, et al. Clinical prognostic factors and management of metastatic castration-resistant prostate cancer: a population-based study. PLoS One. 2015;10(10):e0139440. doi:10.1371/ Ryan, C. J., et al. (2015). "Abiraterone acetate in metastatic prostate cancer: A new era." Journal of Clinical Oncology, 33(10), 1051-1060.6 Kawahara, T., Saigusa, Y., Yoneyama, S. et al. Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide. BMC Cancer 23, 214 (2023). Media contacts:Oncology Media Relations oncology_media_relations@ Investor contact:Lauren Johnsoninvestor-relations@ U.S. Medical Inquiries +1 800 526-7736 View original content to download multimedia: SOURCE Johnson & Johnson Sign in to access your portfolio
Yahoo
13 hours ago
- Yahoo
Casio to Release New MT-G Featuring an Original Frame Co-Created by Humans and AI
Newly Developed Structure Fusing Different Materials TOKYO, May 27, 2025 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the latest addition to the G-SHOCK brand of shock-resistant watches: the MTG-B4000. This new timepiece features a distinctive frame developed in a process of collaboration between human designers and AI technology. The MTG-B4000 joins the MT-G line of timepieces, all of which utilize a unique construction that makes the most of the properties of both metal and resin. The new MTG-B4000 is a shock-resistant watch featuring a distinctive frame that was developed in a process of collaboration between human designers and generative AI and uses a combination of different materials. For the first time in a Casio consumer timepiece, generative AI technology was integrated into the development process. In pursuit of innovative craftsmanship, designers employed this advanced technology as a creative tool to explore new design possibilities and conquer the challenge of realizing a complex, unconventional structure which would have been difficult to achieve using traditional methods. Starting with design proposals from human designers, AI conducted load simulations using decades of accumulated data on shock-resistant construction for G-SHOCK. It then proposed optimal structural configurations by evaluating factors such as structural strength, material characteristics, and machinability. These AI-generated designs were refined through repeated testing and adjustments by skilled human hands, resulting in a frame that delivers the G-SHOCK signature ruggedness with a distinctive, unconventional aesthetic only achievable through AI collaboration. A new approach was also introduced by integrating the band connection parts into the frame. This allows the frame to directly absorb loads applied to the band, reducing impact on the center case and further enhancing shock resistance. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. Any use of such marks and logos by Casio Computer Co., Ltd. is under license. View original content to download multimedia: SOURCE CASIO COMPUTER CO., LTD Sign in to access your portfolio
CNBC
a day ago
- CNBC
Morgan Stanley says buy these five stocks soon that are set to rally
There's a slew of stocks that have a lot more room to run, according to Morgan Stanley. The firm says overweight-rated companies like Nvidia have plenty of upside and remain top picks in June. Others include: Nubank , Sallie Mae , Seagate and Coupang. Seagate The tech data storage company is just too attractive to ignore, analyst Erik Woodring, wrote following Seagate's analyst day in late May. "The inflection in compute will drive exponential growth in storage demand, and we see STX as a still underappreciated play on this theme at just 7.5x our peak EPS," he wrote. And there's a whole host of more positive catalysts to come for top pick Seagate, too, the firm said. "Tech leadership, premium margins, robust FCF generation, and strong cap returns support EPS upside and multiple re-rating from here," he added. The stock is also an undervalued play in the data center space, too, Woodring says. Shares of Seagate are up 36% this year. Coupang The South Korea e-commerce company was recently named a new top pick at the firm. "Competitors have scrambled to respond, but Coupang's market share gains have continued without a blip," analyst Seyon Park wrote. The firm also raised its price target on the stock to $32 per share from $27 as Coupang is firing on all cylinders. "The company continues to execute well, is relatively insulated from tariff risk, and a beneficiary of a weaker USD [US dollar]," he said. Meanwhile, shares are up 27% and remain compelling. "Valuations also look favorable compared to relevant peers, " he went on to say. Nubank The LatAm bank is a share gainer and a top pick at the firm, according analyst Jorge Kuri and team. "We think the market continues to significantly underestimate Nubank's ability to scale profitably — especially through deeper cross-sell in Brazil," they wrote. The firm says Nubank has a differentiated offering for consumers as a one stop shop for all banking needs. "From leading in primary account relationships and salary deposits, to capturing the lion's share of consumer intent in credit card, personal loan, and payroll loan applications and balance transfers, Nubank is clearly far outpacing incumbent and digital peers," he said. The stock is up almost 16% this year, but Kuri says shares have plenty more room to run. "Nubank leads in both reach and relevance," he said succinctly. Seagate "The inflection in compute will drive exponential growth in storage demand, and we see STX as a still underappreciated play on this theme at just 7.5x our peak EPS. Tech leadership, premium margins, robust FCF generation, and strong cap returns support EPS upside and multiple re-rating from here. ... .A (still) underappreciated play on data growth; PT increases to $140 and we reinstate STX as our Top Pick." Coupang "The company continues to execute well, is relatively insulated from tariff risk & a beneficiary of a weaker USD. Valuations also look favorable compared to relevant peers. ... .Competitors have scrambled to respond, but CPNG's market share gains have continued without a blip. ... .Despite the market uncertainties this year, we are quite comfortable CPNG can deliver on its growth targets, while also being a beneficiary of a weaker US dollar." Nvidia "NVIDIA is putting digestion fears fully to rest, showing acceleration of the business other than the China headwinds around growth drivers that seem durable. Everything should get better from here. Reiterate OW, Top Pick in semis. ... .Bear case is fading and inference trajectory is durable; stay with the story. ... .Most of the themes we have been focused on played out through this quarter." Sallie Mae "SLM remains our Top Pick. ... .SLM exploring potential alternatives to whole loan sales, such as JVs, which we think could drive multiple expansion on more consistent asset-light cash flow. ... .Once we gain further clarity on government policy, we expect SLM will formally issue a range of estimates on how much additional volume it can drive in 2H26/2027." Nubank "We think the market continues to significantly underestimate NU's ability to scale profitably — especially through deeper cross-sell in Brazil. ... .From leading in primary account relationships and salary deposits, to capturing the lion's share of consumer intent in credit card, personal loan, and payroll loan applications and balance transfers, NU is clearly far outpacing incumbent and digital peers. ... .Nubank leads in both reach and relevance."
